Suggest "Bridging" Fewer Warfarin Patients With Enoxaparin

You'll see LESS use of "bridging" with low-molecular-weight heparin (enoxaparin, etc) in warfarin patients.

Up to 1 in 6 patients are bridged with an injectable anticoagulant when warfarin is temporarily stopped before surgery or a procedure...hoping to prevent a clot or stroke.

But evidence from the new BRIDGE trial will be a game changer. It suggests that bridging does more harm than good in many patients.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote